Anteris Technologies Global CorpAVR
Price$7.77

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 30 Jun 2026
Market Price $7.77Price as of 30 Sep 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 39.0%/yr (balance of the path).31.4% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 635.2%Yr 731.4%Yr 827.6%Yr 923.8%Yr 1020.0%
39.0% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 11.6%
Volatility vs market (adjusted beta)1.47

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAnteris Technologies Global CorpAVRHealth Care
Valuation
P/E—
P/S366.0×
P/B3.1×
EV / Revenue254.6×
EV / EBITDA-6.6×
Profitability
Gross margin79.8%
Operating margin-4,859.9%
Net margin-4,619.3%
FCF margin-3,934.4%
Returns
ROE-41.2%
ROA-38.0%
ROIC—
Growth
Revenue growth (YoY)-17.1%
5-yr fwd EPS growth31.4%
Financial strength
Debt / Equity0.00×
Current ratio14.20×
Altman Z-Score20.4
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.